Skip to main content
Premium Trial:

Request an Annual Quote

PatternAg Closes $35M Series B Financing Round

NEW YORK – Agricultural technology company PatternAg said on Thursday that it has closed a $35 million Series B funding round.

The round was led by Conti Ventures, with additional investment from Bidra Innovations. Existing investors, including The Production Board, Valor Capital Group, Founders Fund, iSelect, LAUNCH, and Ospraie Ag Science, also joined the round.

Based in Emeryville, California, PatternAg said its metagenomics platform provides data-driven, evidence-based, and long-term predictions about crop risks and nutrient deficiencies at scale in row crops.

The company provides predictive soil analytics that track pest, pathogen, fertility, and nutrient levels for corn and soybean growers across the Midwest, helping farmers predict and plan crop protection, seed selection, and fertility decisions for the upcoming season while controlling input costs.

PatternAg said the Series B funding, which brings the company’s total funding to $60 million, will help expand its intellectual property portfolio that already includes the ​​largest soil metagenomics dataset in the global agriculture industry.

The Scan

Cystatin C Plays Role in Immunosuppression, Cancer Immunotherapy Failure, Study Finds

A study in Cell Genomics provides insight into how glucocorticoids can lead to cancer immunotherapy failure via cystatin C production.

Aging, Species Lifespan Gene Expression Signatures Overlap

An Osaka Metropolitan University team reports in Nucleic Acids Research that transcriptional signatures of aging and maximum lifespan have similarities.

Splicing Subgroup Provides Protocols for Evaluating Splicing Variant Data

The group presents their approach on how to apply evidence codes to splicing predictions and other data in the American Journal of Human Genetics.

Single-Cell Transcriptomic Atlas of Mouse Cochlea to Aid Treatment Development

Researchers in PNAS conducted single-cell and single-nuclear sequencing of about 120,000 cells at three key timepoints in cochlear development to generate a transcriptomic atlas.